Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 26, 2014 08:30 ET | Source: Aldeyra Therapeutics

Aldeyra Therapeutics to Join Russell Microcap Index

BURLINGTON, Mass., June 26, 2014 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...
June 19, 2014 08:30 ET | Source: Aldeyra Therapeutics

Aldeyra Therapeutics Appoints Stephen Tulipano Chief Financial Officer

BURLINGTON, Mass., June 19, 2014 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...
June 11, 2014 08:30 ET | Source: Aldeyra Therapeutics

Aldeyra Therapeutics Reports First Quarter 2014 Financial Results

BURLINGTON, Mass., June 11, 2014 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to...
May 08, 2014 08:30 ET | Source: Aldeyra Therapeutics

Aldeyra Therapeutics' Data on Lead Candidate NS2 to be Presented at Society for Investigative Dermatology 2014 Annual Meeting

BURLINGTON, Mass., May 8, 2014 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
May 07, 2014 18:24 ET | Source: Aldeyra Therapeutics

Aldeyra Therapeutics Announces Closing of Initial Public Offering of 1,500,000 Shares of Common Stock

BURLINGTON, Mass., May 7, 2014 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (Nasdaq:ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to free...
May 01, 2014 20:30 ET | Source: Aldeyra Therapeutics

Aldeyra Therapeutics Prices Initial Public Offering of 1,500,000 Shares of Common Stock

BURLINGTON, Mass., May 1, 2014 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics ("Aldeyra"), a biotechnology company focused on the development of products to treat diseases where free aldehydes are thought...